FUKUSHIMA FUMIYA

Profiles

Profiles

• 氏名

  FUKUSHIMA FUMIYA

Affiliation

• Department of Pulmonary Medicine and Clinical Immunology

Research achievements

Published Papers

Original paper
• 20(2), 167-171, Apr. 2013
• 40(1), 27-37, Mar. 2013
• Relationship between sensitivity to dyspnea and fluctuating peak expiratory flow rate in the absence of asthma symptoms, Kamiya K, Sugiyama KToda MSoda SIkeda NFukushima FHirata HFukushima YFukuda T, Asia Pac Allergy, 2(1), 49-58, Jan. 2012

  DOI
• Patients in whom active tuberculosis was diagnosed after admission to a Japanese university hospital from 2005 through 2007, Fukushima Y, Shiobara KShiobara TTatewaki MAnzai MFukushima FYamada IHirata HSugiyama KFukuda T, J Infect Chemother, 17(5), 652-657, Oct. 2011

  DOI
• Clinical investigation of weekly cisplatin and vinorelbine with concurrent radiation therapy for locally advanced non-small cell lung cancer, Furihata T, Ishii YMiyoshi MFukushima FHayashi YArai RKamiya CTatewaki MFukushima YFukuda T, Gan To Kagaku Ryoho, 38(8), 1313-1316, Aug. 2011
• An analysis of characteristics of patients with exacerbation of asthma in a large university hospital in Japan, Sugiyama K, Yamada IOhara TTatewaki MHayashi YArai RKamiya KFukushima FHirata HArima MFukushima YFukuda T, Asian Pac J Allergy Immunol, 28(4), 242-249, Dec. 2010
• Relation between the antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa from respiratory specimens and antimicrobial use density (AUD) from 2005 through 2008, Fukushima Y, Fukushima FKamiya KHayashi YTatewaki MYamada IHirata HSugiyama KIshii YFukuda T, Intern Med, 49(14), 1333-1340, 2010
• Effects of CD80 and CD86 on cytokine production in patients with wasp-venom allergy who receive venom immunotherapy, Hirata H, Arima MCheng GHonda KAsakura TFukushima FYamaguchi BYoshida NFukuda T, Cytokine, 24(1-2), 1-6, Oct. 2003
• Prostaglandin D2 reinforces Th2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage-derived chemokine, Honda K, Arima MCheng GTaki SHirata HEda FFukushima FYamaguchi BHatano MTokuhisa TFukuda T, J Exp Med, 198(4), 533-543, Aug. 2003

  DOI
• Efficacy and safety of rush immunotherapy in patients with Hymenoptera allergy in Japan, Hirata H, Asakura TArima MCheng GHonda KFukushima FYamaguchi BYoshida NFukuda T, Asian Pac J Allergy Immunol, 21(2), 89-94, Jun. 2003
• Production of TARC and MDC by naive T cells in asthmatic patients, Hirata H, Arima MCheng GHonda KFukushima FYoshida NEda FFukuda T, J Clin Immunol, 23(1), 34-45, Jan. 2003
• Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model, Cheng G, Arima MHonda KHirata HEda FYoshida NFukushima FIshii YFukuda T, Am J Respir Crit Care Med, 166(3), 409-416, Aug. 2002

  DOI
• Interleukin (IL)-4/IL-9 and exogenous IL-16 induce IL-16 production by BEAS-2B cells, a bronchial epithelial cell line, Yoshida N, Arima MCheng GEda FHirata HHonda KFukushima FFukuda T, Cell Immunol, 207(2), 75-80, Feb. 2001

  DOI
• 38(8), 1313-1316, Aug. 2011
• 37(1), 15-20, Mar. 2010

Other
• 52(8), 1537-1540, Aug. 2013
• Riluzole-induced lung injury in two patients with amyotrophic lateral sclerosis, Kakuta T, Hirata HSoda SShiobara TWatanabe MTatewaki MFukushima FChibana KSugiyama KArima MKoichi HFukuda TFukushima Y, Intern Med, 51(14), 1903-1907, 2012

  DOI
• A patient with bronchial asthma in whom eosinophilic bronchitis and bronchiolitis developed during treatment, Fukushima Y, Kamiya KTatewaki MFukushima FHirata HIshii YFukuda T, Allergol Int, 59(1), 87-91, Mar. 2010

  DOI
• 35(1), 115, 2013
• 35(3), 352, 2013
• 36, 30-33, 2006
• 23, 914, Oct. 2003
• 36, 77-86, Dec. 2002
• 22, 325, Apr. 2002
• 83, 1893, May 2001
• 80, 1863, May 1998
• 33(5), 366-370, Sep. 2011
• 39, 161-172, 2012
• 39, 193-199, 2012